Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 18.13
-0.01 (-0.06%)
Apr 29, 2026, 3:00 PM CST
SHA:688276 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -267.12 | -262.58 | 232.09 | 501.01 | 181.54 | 243.55 |
Depreciation & Amortization | 130.96 | 130.96 | 104.18 | 91.99 | 70.94 | 68.34 |
Other Amortization | 19.13 | 19.13 | 9.15 | 7.01 | 5.68 | 0.99 |
Loss (Gain) From Sale of Assets | -0.06 | -0.06 | 2.55 | 0.9 | 0.73 | 2.19 |
Asset Writedown & Restructuring Costs | 72.09 | 72.09 | 0.78 | - | - | - |
Loss (Gain) From Sale of Investments | 34.41 | 34.41 | 0.44 | -0.69 | -0.31 | 1.02 |
Provision & Write-off of Bad Debts | - | - | 6.13 | 31.67 | 12.54 | 5.35 |
Other Operating Activities | 104.64 | 12.61 | 40.06 | 55.96 | 41.34 | 82.59 |
Change in Accounts Receivable | 466.31 | 466.31 | 121.92 | -691.36 | -171.36 | -40.04 |
Change in Inventory | -64.51 | -64.51 | 20.66 | -33.53 | 7.89 | -166.47 |
Change in Accounts Payable | -111.41 | -111.41 | -127.49 | 327.65 | -109.1 | -51.67 |
Operating Cash Flow | 318.7 | 231.21 | 406.5 | 255.21 | 39.82 | 140.3 |
Operating Cash Flow Growth | -7.79% | -43.12% | 59.28% | 540.93% | -71.62% | -32.92% |
Capital Expenditures | -408.78 | -406.49 | -542.43 | -470.66 | -290.73 | -632.88 |
Sale of Property, Plant & Equipment | 0.08 | 0.06 | - | 0.04 | - | 0.02 |
Investment in Securities | - | -50 | - | -168 | - | -62.64 |
Other Investing Activities | - | - | 0.94 | - | 2.02 | - |
Investing Cash Flow | -408.7 | -456.42 | -541.48 | -638.63 | -288.72 | -695.51 |
Short-Term Debt Issued | - | - | - | - | - | 67.5 |
Long-Term Debt Issued | - | 334.65 | 336.84 | 196.91 | - | - |
Total Debt Issued | 388.42 | 334.65 | 336.84 | 196.91 | - | 67.5 |
Short-Term Debt Repaid | - | - | - | - | - | -67.5 |
Long-Term Debt Repaid | - | -172.24 | -254.48 | -176.44 | - | - |
Total Debt Repaid | -225.19 | -172.24 | -254.48 | -176.44 | - | -67.5 |
Net Debt Issued (Repaid) | 163.23 | 162.41 | 82.36 | 20.47 | - | - |
Issuance of Common Stock | - | - | 19 | - | - | 1,413 |
Common Dividends Paid | -76.05 | -75.03 | -62.05 | -62.61 | -41.28 | - |
Other Financing Activities | - | - | -2.35 | - | - | -10.4 |
Financing Cash Flow | 87.19 | 87.38 | 36.97 | -42.14 | -41.28 | 1,402 |
Foreign Exchange Rate Adjustments | -0.19 | -0.16 | 0.7 | 0.5 | 1.66 | -0.1 |
Net Cash Flow | -3 | -138 | -97.31 | -425.06 | -288.52 | 847.05 |
Free Cash Flow | -90.08 | -175.28 | -135.92 | -215.46 | -250.91 | -492.58 |
Free Cash Flow Margin | -15.27% | -28.97% | -11.06% | -11.81% | -23.42% | -40.98% |
Free Cash Flow Per Share | -0.26 | -0.43 | -0.33 | -0.52 | -0.61 | -1.25 |
Cash Interest Paid | - | - | 2.35 | - | - | 0.33 |
Cash Income Tax Paid | 18.77 | 21.99 | 139.52 | 121.49 | 77.93 | 102.54 |
Levered Free Cash Flow | -70.91 | 35.3 | -213.55 | -334.43 | -297.86 | -467.9 |
Unlevered Free Cash Flow | -70.91 | 35.3 | -212.6 | -333.99 | -297.86 | -467.69 |
Change in Working Capital | 224.64 | 224.64 | 11.12 | -432.65 | -293.73 | -269.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.